PDF(Pubmed)
Abstract：
UNASSIGNED: The intramedullary interlocking device for metacarpophalangeal (MCP) joint arthrodesis (XMCP, Extremity Medical, Parsippany, NJ) has been shown to promote union at a precise angle, provide strong fixation without the need for prolonged immobilization, and lower the incidence of hardware irritation and revision surgery. In this study, we evaluated the clinical outcomes of patients undergoing MCP joint arthrodesis with the XMCP system using a retrospective chart review, patient reported outcomes, and radiographic analysis.
UNASSIGNED: A retrospective chart review and phone survey was conducted on 57 patients (58 cases) from a single institution between 2017 and 2022. The primary outcome was patient satisfaction, including pre- and postoperative Numeric Rating Scale (NRS) pain scores, Disabilities of Arm Shoulder and Hand (QuickDASH) outcomes, perceived grip strength, and willingness to undergo the procedure again. Secondary outcomes included the need for revision procedures, successful fusion of arthrodesis, and postoperative complications.
UNASSIGNED: Of the 57 patients who underwent MCP joint arthrodesis of the thumb using the XMCP fusion device, a total of 43 (75%) completed the phone survey. The average age of patients was 67 years with an average clinical follow-up of 9 months (range 1-65 months). Patients who participated in the phone survey questionnaire had an average QuickDASH score of 24.7 ± 20.5. Average perceived NRS scores were 6.2 ± 3.5 and 1.2 ± 2.1 before and after surgery, respectively. Average perceived grip strength of patients was 3 ± 1.3 out of 5. When evaluating for concurrent procedures, there was no statistically significant difference in pre- or postoperative NRS scores. In total, 38 (88%) patients were satisfied with the procedure, and 39 (91%) patients would undergo the procedure again.
UNASSIGNED: Metacarpophalangeal joint arthrodesis of the thumb with the intramedullary fusion device is reproducible, allows for immediate use without immobilization, has a low number of complications, and provides improved function and pain relief.
UNASSIGNED: Therapeutic III.
UNASSIGNED: A retrospective chart review and phone survey was conducted on 57 patients (58 cases) from a single institution between 2017 and 2022. The primary outcome was patient satisfaction, including pre- and postoperative Numeric Rating Scale (NRS) pain scores, Disabilities of Arm Shoulder and Hand (QuickDASH) outcomes, perceived grip strength, and willingness to undergo the procedure again. Secondary outcomes included the need for revision procedures, successful fusion of arthrodesis, and postoperative complications.
UNASSIGNED: Of the 57 patients who underwent MCP joint arthrodesis of the thumb using the XMCP fusion device, a total of 43 (75%) completed the phone survey. The average age of patients was 67 years with an average clinical follow-up of 9 months (range 1-65 months). Patients who participated in the phone survey questionnaire had an average QuickDASH score of 24.7 ± 20.5. Average perceived NRS scores were 6.2 ± 3.5 and 1.2 ± 2.1 before and after surgery, respectively. Average perceived grip strength of patients was 3 ± 1.3 out of 5. When evaluating for concurrent procedures, there was no statistically significant difference in pre- or postoperative NRS scores. In total, 38 (88%) patients were satisfied with the procedure, and 39 (91%) patients would undergo the procedure again.
UNASSIGNED: Metacarpophalangeal joint arthrodesis of the thumb with the intramedullary fusion device is reproducible, allows for immediate use without immobilization, has a low number of complications, and provides improved function and pain relief.
UNASSIGNED: Therapeutic III.
摘要：
■用于掌指关节（MCP）关节固定术（XMCP，极端医疗,Parsippany,NJ）已被证明可以以精确的角度促进工会，提供坚固的固定，而不需要长时间的固定，并降低硬件刺激和翻修手术的发生率。在这项研究中,我们使用回顾性图表评估了使用XMCP系统进行MCP关节固定术的患者的临床结果,患者报告的结果，和射线分析。
■在2017年至2022年之间，对来自单个机构的57名患者（58例）进行了回顾性图表审查和电话调查。主要结果是患者满意度，包括术前和术后数字评定量表（NRS）疼痛评分，臂肩和手的残疾（QuickDASH）结果，感知的握力，并愿意再次接受该程序。次要结果包括需要修订程序，关节固定术成功融合,术后并发症。
■在使用XMCP融合装置进行MCP拇指关节固定术的57例患者中，共有43人(75%)完成了电话调查。患者的平均年龄为67岁，平均临床随访时间为9个月（范围1-65个月）。参加电话调查问卷的患者的平均QuickDASH得分为24.7±20.5。手术前后平均感知NRS评分分别为6.2±3.5和1.2±2.1。分别。患者的平均感知握力为5分之3±1.3。在评估并发程序时，术前或术后NRS评分差异无统计学意义.总的来说,38例（88%）患者对手术感到满意，39名(91%)患者将再次接受手术。
■使用髓内融合器对拇指进行掌指关节固定术是可重复的，允许在不固定的情况下立即使用，并发症数量少，并提供改善的功能和疼痛缓解。
■治疗III.
■在2017年至2022年之间，对来自单个机构的57名患者（58例）进行了回顾性图表审查和电话调查。主要结果是患者满意度，包括术前和术后数字评定量表（NRS）疼痛评分，臂肩和手的残疾（QuickDASH）结果，感知的握力，并愿意再次接受该程序。次要结果包括需要修订程序，关节固定术成功融合,术后并发症。
■在使用XMCP融合装置进行MCP拇指关节固定术的57例患者中，共有43人(75%)完成了电话调查。患者的平均年龄为67岁，平均临床随访时间为9个月（范围1-65个月）。参加电话调查问卷的患者的平均QuickDASH得分为24.7±20.5。手术前后平均感知NRS评分分别为6.2±3.5和1.2±2.1。分别。患者的平均感知握力为5分之3±1.3。在评估并发程序时，术前或术后NRS评分差异无统计学意义.总的来说,38例（88%）患者对手术感到满意，39名(91%)患者将再次接受手术。
■使用髓内融合器对拇指进行掌指关节固定术是可重复的，允许在不固定的情况下立即使用，并发症数量少，并提供改善的功能和疼痛缓解。
■治疗III.
